Search results
Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the...
Simply Wall St. via Yahoo Finance· 19 hours ago(NASDAQ:VKTX) can tell us which group is most powerful. The group holding the most number of shares...
Viking Therapeutics CFO sells over $4.9 million in company stock By Investing.com
Investing.com· 3 days agoIn a recent transaction, Greg Zante, the Chief Financial Officer of Viking Therapeutics, Inc....
Oppenheimer reiterates Viking Therapeutics Inc
Knox Daily· 6 days agoIn a filing, Viking Therapeutics Inc revealed its President & CEO Lian Brian unloaded Company’s shares for reported $1.35 million on ...
Check Out What Whales Are Doing With VKTX - Viking Therapeutics (NASDAQ:VKTX)
Benzinga· 7 days agoThe company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214.
S&P 500: April Selloff Could Be a Very Good Thing for the Months Ahead | Investing.com NG
Investing.com· 1 day agoShares Analysis by Ismael De La Cruz covering: S&P 500, Viking Therapeutics Inc, Tema Obesity &...
Obesity drug rivals aim to unseat Zepbound, Ozempic - Indianapolis Business Journal
Indianapolis Business Journal· 4 days agoInsatiable demand for weight-loss drugs has made the market so feverish that any positive mention of...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune· 4 days agoIndianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss among patients, and Zepbound, an obesity ...